UiPath PATH Stock Slips As Wall Street Slashes Price Targets

UiPath Inc. stocks have been trading down by -5.63 percent after reports of weakening demand for its automation software.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading PATH

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

Multiple banks cut PATH price targets into the low‑teens, signaling fading confidence in near‑term upside despite AI buzz.
Recent Q4 for UiPath showed stabilized net new ARR, but analysts want proof that AI tools can drive durable, high‑margin monetization.
PATH traded like a meme name at times, swinging from a 6.8% gain to a 5.1% premarket drop, highlighting elevated volatility for short‑term trading.
AWS’s push into AI agents rattled software names, raising worries that UiPath’s automation platform may face tougher price and margin pressure.
Street consensus on PATH now sits at Hold, with an average target near $13.93, keeping the stock in “show‑me” territory for many traders.

Live Update At 16:02:06 EDT: On Friday, April 10, 2026 UiPath Inc. stock [NYSE: PATH] is trending down by -5.63%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

PATH has quietly turned into a mixed story that traders cannot ignore. On the one hand, UiPath threw down a solid Q4. Revenue came in around $481.1M, with gross margin at a hefty 83.2%. That kind of margin profile shows UiPath’s software model still has serious economic muscle.

Profitability is finally coming through as well. UiPath posted about $104.5M in net income and EBITDA near $101.5M. Free cash flow of roughly $179.3M and operating cash flow above $182M show PATH is not just burning cash to chase growth anymore. With more than $871M in cash and very low long‑term debt, the balance sheet gives UiPath real staying power while the market debates its future.

More Breaking News

But PATH’s chart tells a different story. Over the last several sessions, the stock slid from the $12s down to the mid‑$9s, with the latest close near $9.38 after opening above $9.90. Intraday, the tape showed a steady grind lower after the open spike, classic weak‑bounce action. For active traders, that combination — improving fundamentals but heavy selling — screams “sentiment problem,” not balance‑sheet risk.

Why Traders Are Watching PATH So Closely

PATH is now a battleground name. UiPath sits right at the center of AI and automation hype, yet the latest news run shows how quickly that story can get repriced when big money turns cautious.

Start with the Street. BMO Capital cut its UiPath price target from $17 to $14, even while acknowledging stabilization in net new ARR and better execution. The message to traders is clear: PATH’s operations are no longer falling apart, but that is not enough. BMO wants direct proof that UiPath’s AI features will translate into durable revenue, not just demos and headlines.

UBS took a similar stance, trimming its PATH target from $17 to $13 after in‑line Q4 numbers. The issue was sluggish constant‑currency net new ARR and only mid‑single‑digit to low‑teens growth guidance. For a supposed AI winner, that growth outlook is lukewarm. When neutral‑rated shops are talking about modest growth despite “AI tailwinds,” traders should respect that caution.

Morgan Stanley and Truist both lowered targets as well, with Morgan Stanley dropping from $19 to $17 and Truist from $17 to $12. Layer in Bank of America, which cut UiPath from $14 to $12 and kept an Underperform rating, and you get a clear picture: big firms are clustering their PATH targets around the low‑teens.

At the same time, macro headlines hit the whole software complex. Reports that AWS is racing ahead with its own AI agents to automate support tasks smacked UiPath, Zscaler, GitLab, and others. Traders worry that if Amazon undercuts pricing or bundles automation into larger cloud deals, companies like UiPath lose leverage fast. That is exactly the kind of competitive overhang that keeps PATH’s valuation multiple compressed, even with improving earnings.

Add the wild swing — up 6.8% one day, down 5.1% premarket the next — and UiPath becomes a name where sentiment can flip on a tweet or a headline. For active trading, that volatility is opportunity. It is also a warning sign for anyone who chases without a plan.

Conclusion

Right now PATH is the definition of a “show‑me” stock. UiPath is posting profits, generating strong cash flow, and running an 83% gross margin business with minimal debt. On paper, that looks like a sturdy platform for long‑term growth. Yet the tape and the banks are sending a different message: until UiPath proves that its AI narrative drives real, sustained ARR acceleration, the stock will likely stay capped. For active traders, that means being extra selective about when and how to trade it. As Tim Bohen, lead trainer with StocksToTrade says, “A good trade setup checks all the boxes—volume, trend, catalyst. Don’t trade if you’re missing pieces of the puzzle.” In PATH’s case, those pieces include not just sector hype, but also confirmation that AI is truly accelerating the business.

The cluster of price target cuts — BMO to $14, UBS to $13, Morgan Stanley to $17, Truist and Bank of America down to $12 — pins PATH’s perceived fair value in a tight band just above current levels. With consensus around $13.93, UiPath does not have the kind of fat upside cushion that momentum traders love. Instead, PATH trades inside a narrow lane where every earnings print and every AI headline from AWS or another giant can yank the stock around.

For traders in the Tim Sykes and Tim Bohen community, this is a classic education setup: hot sector, real company, but a fragile story. The focus is not on predicting where UiPath will be in three years. It is on reading the chart, respecting the analyst overhang, and exploiting the volatility with strict risk rules. As Tim Sykes always says, “Cut losses quickly — that’s your only real edge in a market that does not care about your opinions.” PATH gives plenty of action, but the rules do not change.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!